EP2760853A4 - Neuartige salze aus alogliptin - Google Patents
Neuartige salze aus alogliptinInfo
- Publication number
- EP2760853A4 EP2760853A4 EP12836162.3A EP12836162A EP2760853A4 EP 2760853 A4 EP2760853 A4 EP 2760853A4 EP 12836162 A EP12836162 A EP 12836162A EP 2760853 A4 EP2760853 A4 EP 2760853A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- alogliptin
- novel salts
- salts
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3317CH2011 | 2011-09-26 | ||
PCT/IN2012/000611 WO2013046229A1 (en) | 2011-09-26 | 2012-09-12 | Novel salts of alogliptin |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2760853A1 EP2760853A1 (de) | 2014-08-06 |
EP2760853A4 true EP2760853A4 (de) | 2015-10-28 |
Family
ID=47994371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12836162.3A Withdrawn EP2760853A4 (de) | 2011-09-26 | 2012-09-12 | Neuartige salze aus alogliptin |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2760853A4 (de) |
WO (1) | WO2013046229A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3049402B1 (de) * | 2013-05-24 | 2019-02-27 | Glenmark Pharmaceuticals Limited | Verfahren zur herstellung von alogliptin |
CN104725350A (zh) * | 2013-12-23 | 2015-06-24 | 湖北华世通生物医药科技有限公司 | 阿格列汀盐酸盐的多晶b型晶体、其制备方法及生产用途 |
CN103923063B (zh) * | 2014-04-11 | 2016-05-11 | 浙江永宁药业股份有限公司 | 一种苯甲酸阿格列汀的晶型及其制备方法 |
US20190023683A1 (en) | 2015-05-04 | 2019-01-24 | Indoco Remedies Limited | Process for the preparation of alogliptin |
WO2017107945A1 (zh) * | 2015-12-24 | 2017-06-29 | 山东轩竹医药科技有限公司 | 二肽基肽酶-iv抑制剂的苯甲酸盐的晶型 |
CN109219607B (zh) * | 2016-06-08 | 2021-03-30 | 吉林惠升生物制药有限公司 | 二肽基肽酶-iv抑制剂的丁二酸盐的晶型 |
CN105929084B (zh) * | 2016-07-18 | 2018-11-23 | 江苏德源药业股份有限公司 | 高效液相色谱拆分苯甲酸阿格列汀及其对映异构体的方法 |
CN106749177A (zh) * | 2016-12-30 | 2017-05-31 | 湖南千金湘江药业股份有限公司 | 一种苯甲酸阿格列汀的精制方法 |
CN113880900B (zh) * | 2020-10-30 | 2023-07-07 | 杭州拉林智能科技有限公司 | 黄酮苷-有机胺类dpp-4抑制剂复盐化合物及其制备方法和应用 |
CN113698384B (zh) * | 2021-10-26 | 2022-01-18 | 上海维京生物医药科技有限公司 | 阿格列汀没食子酸盐及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005095381A1 (en) * | 2004-03-15 | 2005-10-13 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
WO2007033266A2 (en) * | 2005-09-14 | 2007-03-22 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors for treating diabetis |
WO2007035629A2 (en) * | 2005-09-16 | 2007-03-29 | Takeda Pharmaceutical Company Limited | Process for the preparation of pyrimidinedione derivatives |
WO2010109468A1 (en) * | 2009-03-26 | 2010-09-30 | Mapi Pharma Hk Limited | Process for the preparation of alogliptin |
WO2011141903A1 (en) * | 2010-05-12 | 2011-11-17 | Mapi Pharma Holdings (Cyprus) Limited | Polymorphs of alogliptin benzoate |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1661878A1 (de) * | 2004-11-26 | 2006-05-31 | Dipharma S.p.A. | Polymorphe Formen von Adapalene |
TW200745079A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
US20110159084A1 (en) * | 2008-04-02 | 2011-06-30 | Dr. Reddy's Laboratories Ltd. | Raloxifene pharmaceutical formulations |
-
2012
- 2012-09-12 EP EP12836162.3A patent/EP2760853A4/de not_active Withdrawn
- 2012-09-12 WO PCT/IN2012/000611 patent/WO2013046229A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005095381A1 (en) * | 2004-03-15 | 2005-10-13 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
WO2007033266A2 (en) * | 2005-09-14 | 2007-03-22 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors for treating diabetis |
WO2007035629A2 (en) * | 2005-09-16 | 2007-03-29 | Takeda Pharmaceutical Company Limited | Process for the preparation of pyrimidinedione derivatives |
WO2010109468A1 (en) * | 2009-03-26 | 2010-09-30 | Mapi Pharma Hk Limited | Process for the preparation of alogliptin |
WO2011141903A1 (en) * | 2010-05-12 | 2011-11-17 | Mapi Pharma Holdings (Cyprus) Limited | Polymorphs of alogliptin benzoate |
Non-Patent Citations (1)
Title |
---|
See also references of WO2013046229A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2013046229A1 (en) | 2013-04-04 |
EP2760853A1 (de) | 2014-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1244183A1 (zh) | Ivacaftor的氘化衍生物 | |
HUE047354T2 (hu) | Ivacaftor deuterizált származékai | |
EP2712362A4 (de) | Herstellung von lacto-n-tetraose | |
IL229830B (en) | Novel compinds as modulatord of gpr-119 | |
EP2723384A4 (de) | Behandlung von proteinopathien | |
EP2673286A4 (de) | Therapeutische verbindungen | |
EP2742051A4 (de) | Amorphe form von dolutegravir | |
IL232599A (en) | Hydrobromide salt of peridofidine | |
EP2717855A4 (de) | Behandlungsverfahren | |
EP2760853A4 (de) | Neuartige salze aus alogliptin | |
IL230976A0 (en) | Crystalline forms of cvezitaxel | |
GB201304499D0 (en) | Carcainium Salts | |
HK1195770A1 (en) | Amorphous solid salts of cobicistat (gs-9350) (cobicistat)(gs-9350) | |
HK1203355A1 (en) | Uses of 4-desferrithiocin analogs 4- | |
EP2785766A4 (de) | Hydroxypolyaminsalze | |
EP2601178A4 (de) | Salze von lapatinib | |
EP2684869A4 (de) | Herstellung von 3-mercaptopropionaten | |
EP2680843A4 (de) | Derivate von pyrazolsubstituierten amino-heteroaryl-verbindungen | |
IL230977A (en) | A crystalline form of relapaldib | |
EP2782902A4 (de) | Derivate aus phenoxyisobuttersäure | |
PL395425A1 (pl) | Sposób wytwarzania chlorowodorku 2-amino-N-tert-butylo-2- cyjanoacetamidu | |
EP2702991A4 (de) | Zusammensetzung von entacopon | |
GB201102913D0 (en) | Novel therapeutic | |
GB201106819D0 (en) | Novel salts | |
GB201104632D0 (en) | Use of medicament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20140402 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07D 401/04 20060101AFI20150310BHEP |
|
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20150924 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07D 401/04 20060101AFI20150918BHEP |
|
17Q | First examination report despatched |
Effective date: 20160916 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20170923 |